Kerry Ingalls - Chief Operating Officer, Poseida Therapeutics, Inc

As of November 18, 2021


Kerry Ingalls Net Worth

  • Net worth is estimated to be at least $18.46K
  • Owns at least 2,000 units of Poseida Therapeutics, Inc stock

Kerry Ingalls Trading

  • Largest purchase of shares was 2,000 units , worth over $14K on November 18, 2021
  • In total has made about 2 transactions over 10 months
  • Usually trades in February and November, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kerry Ingalls Mailing Address

  • Mailing address is C/o Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Suite 200 San Diego CA 92121 CA

Poseida Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Eric Ostertag, M.D., Ph.D. 2020 $548,115 - $301,460 $9,102 $858,677
Eric Ostertag, M.D., Ph.D. 2019 $462,419 $2,024,600 $232,337 $8,400 $2,727,756
Mark J. Gergen, J.D. 2020 $432,680 $804,500 $194,710 $9,102 $1,440,992
Harry J. Leonhardt, J.D. 2020 $197,235 $1,720,402 $78,890 $5,401 $2,001,928
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661460/000156459021021414/pstx-def14a_20210616.htm

Poseida Therapeutics, Inc Insider Trading

  • The most recent transaction was 51,253 units bought on December 2, 2021 by Malin Life Sciences Holdings Ltd worth over $351.19K
  • In the last year, insiders at Poseida Therapeutics, Inc sold an estimated value of $7.47M and bought an estimated value of $9.54M
  • The most active traders are Eric Ostertag, Chief Executive Officer,  Matthew Spear, Chief Medical Officer,  and Malin Life Sciences Holdings Ltd
  • Insider trading is most common in July, with the busiest year in 2021

Poseida Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1